139 related articles for article (PubMed ID: 36931102)
1. Tumor-associated macrophages induce inflammation and drug resistance in a mechanically tunable engineered model of osteosarcoma.
Chim LK; Williams IL; Bashor CJ; Mikos AG
Biomaterials; 2023 May; 296():122076. PubMed ID: 36931102
[TBL] [Abstract][Full Text] [Related]
2. Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcoma.
Molina ER; Chim LK; Salazar MC; Mehta SM; Menegaz BA; Lamhamedi-Cherradi SE; Satish T; Mohiuddin S; McCall D; Zaske AM; Cuglievan B; Lazar AJ; Scott DW; Grande-Allen JK; Ludwig JA; Mikos AG
Acta Biomater; 2019 Dec; 100():38-51. PubMed ID: 31542501
[TBL] [Abstract][Full Text] [Related]
3. Changes in the gene expression of co-cultured human fibroblast cells and osteosarcoma cells: the role of microenvironment.
Salvatore V; Focaroli S; Teti G; Mazzotti A; Falconi M
Oncotarget; 2015 Oct; 6(30):28988-98. PubMed ID: 26418748
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
[TBL] [Abstract][Full Text] [Related]
5. The role of tumor-associated macrophages in osteosarcoma progression - therapeutic implications.
Huang Q; Liang X; Ren T; Huang Y; Zhang H; Yu Y; Chen C; Wang W; Niu J; Lou J; Guo W
Cell Oncol (Dordr); 2021 Jun; 44(3):525-539. PubMed ID: 33788151
[TBL] [Abstract][Full Text] [Related]
6. Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling.
Lu M; Xie K; Lu X; Lu L; Shi Y; Tang Y
Invest New Drugs; 2021 Apr; 39(2):416-425. PubMed ID: 33128383
[TBL] [Abstract][Full Text] [Related]
7. Pivotal role of IL-8 derived from the interaction between osteosarcoma and tumor-associated macrophages in osteosarcoma growth and metastasis via the FAK pathway.
Tatsuno R; Ichikawa J; Komohara Y; Pan C; Kawasaki T; Enomoto A; Aoki K; Hayakawa K; Iwata S; Jubashi T; Haro H
Cell Death Dis; 2024 Feb; 15(2):108. PubMed ID: 38302407
[TBL] [Abstract][Full Text] [Related]
8. HMGB1 Positive Feedback Loop Between Cancer Cells and Tumor-Associated Macrophages Promotes Osteosarcoma Migration and Invasion.
Hou C; Lu M; Lei Z; Dai S; Chen W; Du S; Jin Q; Zhou Z; Li H
Lab Invest; 2023 May; 103(5):100054. PubMed ID: 36801636
[TBL] [Abstract][Full Text] [Related]
9. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
10. YAP/STAT3 inhibited CD8
Wang C; Shen N; Guo Q; Tan X; He S
Cancer Med; 2023 Aug; 12(15):16295-16309. PubMed ID: 37329188
[TBL] [Abstract][Full Text] [Related]
11. Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization.
Zhao X; Wang X; You Y; Wen D; Feng Z; Zhou Y; Que K; Gong J; Liu Z
Exp Cell Res; 2020 Jun; 391(1):111979. PubMed ID: 32246992
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
13. Onionin A inhibits small-cell lung cancer proliferation through suppressing STAT3 activation induced by macrophages-derived IL-6 and cell-cell interaction with tumor-associated macrophage.
Mito R; Iriki T; Fujiwara Y; Pan C; Ikeda T; Nohara T; Suzuki M; Sakagami T; Komohara Y
Hum Cell; 2023 May; 36(3):1068-1080. PubMed ID: 36961655
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated macrophages in osteosarcoma.
Zhao Y; Zhang B; Zhang Q; Ma X; Feng H
J Zhejiang Univ Sci B; 2021 Nov; 22(11):885-892. PubMed ID: 34783219
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy.
Cersosimo F; Lonardi S; Bernardini G; Telfer B; Mandelli GE; Santucci A; Vermi W; Giurisato E
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32717819
[TBL] [Abstract][Full Text] [Related]
16. Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion.
Yang J; Xing Z
Exp Biol Med (Maywood); 2021 Sep; 246(17):1928-1937. PubMed ID: 34053234
[TBL] [Abstract][Full Text] [Related]
17. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
18. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
Dieudonné FX; Marion A; Marie PJ; Modrowski D
J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
[TBL] [Abstract][Full Text] [Related]
19. Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.
Ryu K; Susa M; Choy E; Yang C; Hornicek FJ; Mankin HJ; Duan Z
BMC Cancer; 2010 May; 10():187. PubMed ID: 20459702
[TBL] [Abstract][Full Text] [Related]
20. The tumor microenvironment promotes cancer progression and cell migration.
Salvatore V; Teti G; Focaroli S; Mazzotti MC; Mazzotti A; Falconi M
Oncotarget; 2017 Feb; 8(6):9608-9616. PubMed ID: 28030810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]